Form 4: PTC Therapeutics Director Stephanie Okey Sells 5,000 Shares
SEC Form 4 Filing
Director Stephanie Okey sold 5,000 shares of PTC Therapeutics (PTCT) common stock at $54 per share on March 13, 2025.
Summary
- On March 13, 2025, Stephanie Okey, a director of PTC Therapeutics, Inc. (PTCT), sold 5,000 shares of common stock.
- The sale price was $54 per share.
- Following the transaction, Okey directly owns 8,867 shares of PTCT common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales of shares by company directors are a normal part of corporate governance. It is difficult to assess the impact of this sale without knowing the director's overall holdings and reasons for selling.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale relative to the director's total holdings.
Key Dates
| Date | Description |
|---|---|
| 03/13/2025 | Date of transaction: Stephanie Okey sold 5,000 shares of PTC Therapeutics common stock. |
| 03/17/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.